Left Brain Wealth Management LLC Acquires 1,923 Shares of McKesson Corporation $MCK

Left Brain Wealth Management LLC raised its holdings in McKesson Corporation (NYSE:MCK) by 39.0% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 6,848 shares of the company’s stock after buying an additional 1,923 shares during the quarter. McKesson accounts for about 1.9% of Left Brain Wealth Management LLC’s investment portfolio, making the stock its 19th largest holding. Left Brain Wealth Management LLC’s holdings in McKesson were worth $5,617,000 as of its most recent filing with the SEC.

A number of other large investors have also recently made changes to their positions in MCK. Brighton Jones LLC grew its position in shares of McKesson by 46.3% in the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after buying an additional 798 shares during the last quarter. Caxton Associates LLP bought a new stake in shares of McKesson in the 1st quarter worth approximately $233,000. Sivia Capital Partners LLC grew its position in shares of McKesson by 77.9% in the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after buying an additional 300 shares during the last quarter. Treasurer of the State of North Carolina grew its position in shares of McKesson by 0.9% in the 2nd quarter. Treasurer of the State of North Carolina now owns 58,623 shares of the company’s stock worth $42,958,000 after buying an additional 508 shares during the last quarter. Finally, Osterweis Capital Management Inc. bought a new stake in shares of McKesson in the 2nd quarter worth approximately $166,000. 85.07% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently weighed in on MCK. UBS Group lifted their price objective on McKesson from $1,000.00 to $1,050.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. Weiss Ratings restated a “buy (b+)” rating on shares of McKesson in a research note on Monday, May 4th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $875.00 target price on shares of McKesson in a research note on Friday, May 8th. Wall Street Zen upgraded McKesson from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Finally, Morgan Stanley restated an “overweight” rating and issued a $966.00 target price on shares of McKesson in a research note on Thursday, January 29th. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $968.87.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Michele Lau sold 2,725 shares of McKesson stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the transaction, the executive vice president owned 3,247 shares in the company, valued at approximately $3,214,530. The trade was a 45.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Leann B. Smith sold 190 shares of McKesson stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the transaction, the executive vice president owned 2,989 shares of the company’s stock, valued at $2,824,605. The trade was a 5.98% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 3,264 shares of company stock worth $3,205,315. 0.08% of the stock is owned by insiders.

McKesson Stock Up 1.7%

MCK opened at $759.82 on Friday. The stock has a market cap of $91.33 billion, a PE ratio of 19.75, a PEG ratio of 1.11 and a beta of 0.35. The business has a 50 day moving average of $854.83 and a 200-day moving average of $857.22. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00.

McKesson (NYSE:MCK) last released its earnings results on Thursday, May 7th. The company reported $11.69 EPS for the quarter, beating analysts’ consensus estimates of $11.56 by $0.13. The company had revenue of $96.30 billion during the quarter, compared to analysts’ expectations of $101.35 billion. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The firm’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same quarter last year, the business posted $10.12 EPS. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. Equities analysts anticipate that McKesson Corporation will post 44.29 EPS for the current year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be paid a dividend of $0.82 per share. The ex-dividend date is Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s payout ratio is presently 8.53%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.